Centre for Addiction and Mental Health (CAMH)
Runhao Zhou has not added Biography.
If you are Runhao Zhou and would like to personalize this page please email our Author Liaison for assistance.
Influence of CYP2D6 and CYP2C19 gene variants on antidepressant response in obsessive-compulsive disorder.
The pharmacogenomics journal Apr, 2014 | Pubmed ID: 23545896
Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo.
Pharmacogenetics and genomics Feb, 2014 | Pubmed ID: 24305170
Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers.
Clinical pharmacology and therapeutics Aug, 2014 | Pubmed ID: 24733007
Gene variants in CYP2C19 are associated with altered in vivo bupropion pharmacokinetics but not bupropion-assisted smoking cessation outcomes.
Drug metabolism and disposition: the biological fate of chemicals Nov, 2014 | Pubmed ID: 25187485
Mutations in DCPS and EDC3 in autosomal recessive intellectual disability indicate a crucial role for mRNA decapping in neurodevelopment.
Human molecular genetics Jun, 2015 | Pubmed ID: 25701870
The fatty acid amide hydrolase C385A variant affects brain binding of the positron emission tomography tracer [11C]CURB.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism Aug, 2015 | Pubmed ID: 26036940
CYP2A6 genotyping methods and strategies using real-time and end point PCR platforms.
Pharmacogenomics , 2016 | Pubmed ID: 26670214
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Lancet (London, England) Aug, 2016 | Pubmed ID: 27289172
Mutations disrupting neuritogenesis genes confer risk for cerebral palsy.
Nature genetics Oct, 2020 | Pubmed ID: 32989326
Author Correction: Mutations disrupting neuritogenesis genes confer risk for cerebral palsy.
Nature genetics Mar, 2021 | Pubmed ID: 33432185
Electroconvulsive therapy with a memory reactivation intervention for post-traumatic stress disorder: A randomized controlled trial.
Brain stimulation , 2021 | Pubmed ID: 33785406
Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology.
Nature genetics Jun, 2021 | Pubmed ID: 34002096
Serum amyloid P component level is associated with clinical response to escitalopram treatment in patients with major depressive disorder.
Journal of psychiatric research Feb, 2022 | Pubmed ID: 34995992
The D2R-DISC1 protein complex and associated proteins are altered in schizophrenia and normalized with antipsychotic treatment.
Journal of psychiatry & neuroscience : JPN , 2022 | Pubmed ID: 35361701
Mapping genomic loci implicates genes and synaptic biology in schizophrenia.
Nature 04, 2022 | Pubmed ID: 35396580
Distinct Age-Related Clinical Features and Risk Assessment in Chinese With Chronic Lymphocytic Leukemia.
Frontiers in oncology , 2022 | Pubmed ID: 35646669
The GR-FKBP51 interaction modulates fear memory but not spatial or recognition memory.
Progress in neuro-psychopharmacology & biological psychiatry Dec, 2022 | Pubmed ID: 35839967
Serum amyloid P component (SAP) modulates antidepressant effects through promoting membrane insertion of the serotonin transporter.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology Feb, 2023 | Pubmed ID: 36076020
Prognosis and complications of patients with primary gastrointestinal diffuse large B-cell lymphoma: Development and validation of the systemic inflammation response index-covered score.
Cancer medicine Apr, 2023 | Pubmed ID: 36866830
BigNeuron: a resource to benchmark and predict performance of algorithms for automated tracing of neurons in light microscopy datasets.
Nature methods Apr, 2023 | Pubmed ID: 37069271
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유